271 related articles for article (PubMed ID: 14649881)
1. Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas.
Weaver M; Laske DW
J Neurooncol; 2003 Oct; 65(1):3-13. PubMed ID: 14649881
[TBL] [Abstract][Full Text] [Related]
2. Vascular protection by chloroquine during brain tumor therapy with Tf-CRM107.
Hagihara N; Walbridge S; Olson AW; Oldfield EH; Youle RJ
Cancer Res; 2000 Jan; 60(2):230-4. PubMed ID: 10667564
[TBL] [Abstract][Full Text] [Related]
3. Mathematical modeling of mutant transferrin-CRM107 molecular conjugates for cancer therapy.
Yoon DJ; Chen KY; Lopes AM; Pan AA; Shiloach J; Mason AB; Kamei DT
J Theor Biol; 2017 Mar; 416():88-98. PubMed ID: 28065783
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice.
Laske DW; Ilercil O; Akbasak A; Youle RJ; Oldfield EH
J Neurosurg; 1994 Mar; 80(3):520-6. PubMed ID: 8113865
[TBL] [Abstract][Full Text] [Related]
5. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors.
Laske DW; Youle RJ; Oldfield EH
Nat Med; 1997 Dec; 3(12):1362-8. PubMed ID: 9396606
[TBL] [Abstract][Full Text] [Related]
6. Clinical studies with targeted toxins in malignant glioma.
Rainov NG; Söling A
Rev Recent Clin Trials; 2006 May; 1(2):119-31. PubMed ID: 18473963
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals.
Engebraaten O; Hjortland GO; Juell S; Hirschberg H; Fodstad O
Int J Cancer; 2002 Feb; 97(6):846-52. PubMed ID: 11857366
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of transferrin iron release increases in vitro drug carrier efficacy.
Lao BJ; Tsai WL; Mashayekhi F; Pham EA; Mason AB; Kamei DT
J Control Release; 2007 Feb; 117(3):403-12. PubMed ID: 17239470
[TBL] [Abstract][Full Text] [Related]
9. Clinical trials with intracerebral convection-enhanced delivery of targeted toxins in malignant glioma.
Rainov NG; Gorbatyuk K; Heidecke V
Rev Recent Clin Trials; 2008 Jan; 3(1):2-9. PubMed ID: 18474010
[TBL] [Abstract][Full Text] [Related]
10. Distinct cellular responses induced by saporin and a transferrin-saporin conjugate in two different human glioblastoma cell lines.
Cimini A; Mei S; Benedetti E; Laurenti G; Koutris I; Cinque B; Cifone MG; Galzio R; Pitari G; Di Leandro L; Giansanti F; Lombardi A; Fabbrini MS; Ippoliti R
J Cell Physiol; 2012 Mar; 227(3):939-51. PubMed ID: 21503892
[TBL] [Abstract][Full Text] [Related]
11. Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.
Tortorella S; Karagiannis TC
J Membr Biol; 2014 Apr; 247(4):291-307. PubMed ID: 24573305
[TBL] [Abstract][Full Text] [Related]
12. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
[TBL] [Abstract][Full Text] [Related]
13. Convection-enhanced delivery in clinical trials.
Hall WA; Rustamzadeh E; Asher AL
Neurosurg Focus; 2003 Feb; 14(2):e2. PubMed ID: 15727423
[TBL] [Abstract][Full Text] [Related]
14. Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.
Ferguson S; Lesniak MS
Curr Drug Deliv; 2007 Apr; 4(2):169-80. PubMed ID: 17456036
[TBL] [Abstract][Full Text] [Related]
15. Diphtheria toxin-based targeted toxin therapy for brain tumors.
Li YM; Vallera DA; Hall WA
J Neurooncol; 2013 Sep; 114(2):155-64. PubMed ID: 23695514
[TBL] [Abstract][Full Text] [Related]
16. Diphtheria toxin mutant selectively kills cerebellar Purkinje neurons.
Riedel CJ; Muraszko KM; Youle RJ
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5051-5. PubMed ID: 2367523
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of protein synthesis inhibition and recovery in CRM107 immunotoxin-treated HeLa cells.
Wenning LA; Yazdi PT; Murphy RM
Biotechnol Bioeng; 1998 Feb; 57(4):484-96. PubMed ID: 10099226
[TBL] [Abstract][Full Text] [Related]
18. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations.
Liu G; Shen H; Mao J; Zhang L; Jiang Z; Sun T; Lan Q; Zhang Z
ACS Appl Mater Interfaces; 2013 Aug; 5(15):6909-14. PubMed ID: 23883622
[TBL] [Abstract][Full Text] [Related]
19. Convection-enhanced delivery: targeted toxin treatment of malignant glioma.
Hall WA; Sherr GT
Neurosurg Focus; 2006 Apr; 20(4):E10. PubMed ID: 16709015
[TBL] [Abstract][Full Text] [Related]
20. Transferrin toxin but not transferrin receptor immunotoxin is influenced by free transferrin and iron saturation.
Gosselaar PH; van-Dijk AJ; de-Gast GC; Polito L; Bolognesi A; Vooijs WC; Verheul AF; Krouwer HG; Marx JJ
Eur J Clin Invest; 2002 Mar; 32 Suppl 1():61-9. PubMed ID: 11886434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
